Physical interaction of two cancer-testisantigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)

Cancer immunity

Andrew J. G. Simpson²  Cathy A. Ferrera⁴  Hasina H. Outtz⁴  Sacha Gnjatic²  Andre L. Vettore¹  Otavia L. Caballero²  Hearn J. Cho⁴  Yao-Tseng Chen⁴  Sheila Fortunato²  Valéria C. C. Andrade³  Ramon Chua²  Lloyd J. Old²  Achim A. Jungbluth²  Nasser Altorki⁴  Gisele W. Colleoni³ 

[1] Ludwig Institute for Cancer Research,Sao Paulo Branch, Sao Paulo, SP, BrazilLudwig Institute for Cancer Research,Sao Paulo Branch, Sao Paulo, SP, BrazilLudwig Institute for Cancer Research,Sao Paulo Branch, Sao Paulo, SP, Brazil;Ludwig Institute for Cancer Research,New York Branch at Memorial Sloan-Kettering Cancer Center, 1275York Avenue, New York, NY 10021, USALudwig Institute for Cancer Research,New York Branch at Memorial Sloan-Kettering Cancer Center, 1275York Avenue, New York, NY 10021, USALudwig Institute for Cancer Research,New York Branch at Memorial Sloan-Kettering Cancer Center, 1275York Avenue, New York, NY 10021, USA;Escola Paulista de Medicina, UniversidadeFederal de Sao Paulo, Sao Paulo, SP, BrazilEscola Paulista de Medicina, UniversidadeFederal de Sao Paulo, Sao Paulo, SP, BrazilEscola Paulista de Medicina, UniversidadeFederal de Sao Paulo, Sao Paulo, SP, Brazil;Weill Medical College of Cornell University, 1300York Avenue, New York, NY 10021, USAWeill Medical College of Cornell University, 1300York Avenue, New York, NY 10021, USAWeill Medical College of Cornell University, 1300York Avenue, New York, NY 10021, USA

关键词: two-hybrid assay;    MAGE-C1;    NY-ESO-1;    human;    multiple myeloma;    NSCLC;    RT-PCR;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown